Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Pierre R Breber
Director
Disclosures on record
27
Companies involved
3
Their past purchases, 90 days after disclosure
2 buys, median +14.3% vs S&P 500, beat it 2 of 2 times.
Average +14.3% vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 24, 2025 to May 5, 2026, measured from the first close after the filing. Past results, not a forecast.
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Compensation award — excluded from discretionary-purchase analysis.
Director bought
~$429KReported value · 5,000 sh @ $85.8248
Stock since the trade -6.3% · S&P 500 +5.6% · to Oct 1
A board member of Clorox spent $429K of their very own money to buy Clorox shares. It was the first time in 6 months that they bought. Their pile of Clorox shares grew by 39%.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Compensation award — excluded from discretionary-purchase analysis.
Not classified as an open-market trade.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Not classified as an open-market trade.
Not classified as an open-market trade.
Director bought
~$417KReported value · 4,000 sh @ $104.1291
Stock since the trade -22.4% · S&P 500 +15.9% · to Oct 1
A board member of Clorox spent $417K of their very own money to buy Clorox shares. Their pile of Clorox shares grew by 44%.